Annual Revenue
$1.31 B
+$140.40 M+12.01%
31 March 2024
Summary:
Haemonetics annual revenue is currently $1.31 billion, with the most recent change of +$140.40 million (+12.01%) on 31 March 2024. During the last 3 years, it has risen by +$438.59 million (+50.39%). HAE annual revenue is now at all-time high.HAE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$345.51 M
+$9.34 M+2.78%
28 September 2024
Summary:
Haemonetics quarterly revenue is currently $345.51 million, with the most recent change of +$9.34 million (+2.78%) on 28 September 2024. Over the past year, it has increased by +$27.33 million (+8.59%). HAE quarterly revenue is now at all-time high.HAE Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$1.36 B
+$27.33 M+2.05%
28 September 2024
Summary:
Haemonetics TTM revenue is currently $1.36 billion, with the most recent change of +$27.33 million (+2.05%) on 28 September 2024. Over the past year, it has increased by +$121.99 million (+9.84%). HAE TTM revenue is now at all-time high.HAE TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HAE Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.0% | +8.6% | +9.8% |
| 3 y3 years | +50.4% | +33.0% | +42.8% |
| 5 y5 years | +35.3% | +36.8% | +37.8% |
HAE Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +50.4% | at high | +44.0% | at high | +45.8% |
| 5 y | 5 years | at high | +50.4% | at high | +76.7% | at high | +56.4% |
| alltime | all time | at high | +732.2% | at high | +779.2% | at high | +3363.7% |
Haemonetics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $345.51 M(+2.8%) | $1.36 B(+2.0%) |
| June 2024 | - | $336.17 M(-2.1%) | $1.33 B(+1.9%) |
| Mar 2024 | $1.31 B(+12.0%) | - | - |
| Mar 2024 | - | $343.29 M(+2.1%) | $1.31 B(+3.1%) |
| Dec 2023 | - | $336.25 M(+5.7%) | $1.27 B(+2.5%) |
| Sept 2023 | - | $318.18 M(+2.2%) | $1.24 B(+1.7%) |
| June 2023 | - | $311.33 M(+2.3%) | $1.22 B(+4.3%) |
| Mar 2023 | $1.17 B(+17.7%) | $304.42 M(-0.3%) | $1.17 B(+3.5%) |
| Dec 2022 | - | $305.30 M(+2.6%) | $1.13 B(+4.2%) |
| Sept 2022 | - | $297.49 M(+13.8%) | $1.08 B(+5.6%) |
| June 2022 | - | $261.46 M(-1.3%) | $1.03 B(+3.3%) |
| Mar 2022 | $993.20 M(+14.1%) | $265.00 M(+2.0%) | $993.20 M(+4.2%) |
| Dec 2021 | - | $259.77 M(+8.3%) | $953.22 M(+2.1%) |
| Sept 2021 | - | $239.90 M(+5.0%) | $933.83 M(+3.4%) |
| June 2021 | - | $228.53 M(+1.6%) | $903.41 M(+3.8%) |
| Mar 2021 | $870.46 M(-11.9%) | $225.03 M(-6.4%) | $870.46 M(-1.5%) |
| Dec 2020 | - | $240.37 M(+14.7%) | $883.93 M(-2.1%) |
| Sept 2020 | - | $209.49 M(+7.1%) | $902.52 M(-4.6%) |
| June 2020 | - | $195.58 M(-18.0%) | $945.61 M(-4.3%) |
| Mar 2020 | $988.48 M(+2.2%) | $238.49 M(-7.9%) | $988.48 M(-1.1%) |
| Dec 2019 | - | $258.97 M(+2.5%) | $999.28 M(+1.2%) |
| Sept 2019 | - | $252.57 M(+5.9%) | $987.67 M(+1.1%) |
| June 2019 | - | $238.45 M(-4.3%) | $976.68 M(+0.9%) |
| Mar 2019 | $967.58 M(+7.0%) | $249.29 M(+0.8%) | $967.58 M(+1.7%) |
| Dec 2018 | - | $247.36 M(+2.4%) | $951.84 M(+1.4%) |
| Sept 2018 | - | $241.58 M(+5.3%) | $938.52 M(+1.8%) |
| June 2018 | - | $229.35 M(-1.8%) | $922.32 M(+2.0%) |
| Mar 2018 | $903.92 M(+2.0%) | $233.55 M(-0.2%) | $903.92 M(+0.6%) |
| Dec 2017 | - | $234.04 M(+3.8%) | $898.44 M(+0.7%) |
| Sept 2017 | - | $225.38 M(+6.8%) | $892.24 M(+0.6%) |
| June 2017 | - | $210.95 M(-7.5%) | $887.11 M(+0.1%) |
| Mar 2017 | $886.12 M(-2.5%) | $228.07 M(+0.1%) | $886.12 M(-1.6%) |
| Dec 2016 | - | $227.84 M(+3.4%) | $900.39 M(-0.6%) |
| Sept 2016 | - | $220.25 M(+4.9%) | $905.93 M(+0.1%) |
| June 2016 | - | $209.96 M(-13.4%) | $905.38 M(-0.4%) |
| Mar 2016 | $908.83 M(-0.2%) | $242.34 M(+3.8%) | $908.83 M(+1.8%) |
| Dec 2015 | - | $233.38 M(+6.2%) | $892.97 M(+0.2%) |
| Sept 2015 | - | $219.69 M(+2.9%) | $891.41 M(-0.9%) |
| June 2015 | - | $213.41 M(-5.8%) | $899.30 M(-1.2%) |
| Mar 2015 | $910.37 M(-3.0%) | $226.48 M(-2.3%) | $910.37 M(-1.6%) |
| Dec 2014 | - | $231.83 M(+1.9%) | $924.99 M(-1.1%) |
| Sept 2014 | - | $227.58 M(+1.4%) | $935.28 M(-0.9%) |
| June 2014 | - | $224.49 M(-6.9%) | $943.45 M(+0.5%) |
| Mar 2014 | $938.51 M(+5.2%) | $241.09 M(-0.4%) | $938.51 M(-0.9%) |
| Dec 2013 | - | $242.12 M(+2.7%) | $947.36 M(-0.6%) |
| Sept 2013 | - | $235.75 M(+7.4%) | $952.63 M(+1.9%) |
| June 2013 | - | $219.54 M(-12.2%) | $935.06 M(+4.8%) |
| Mar 2013 | $891.99 M(+22.6%) | $249.94 M(+1.0%) | $891.99 M(+7.6%) |
| Dec 2012 | - | $247.40 M(+13.4%) | $828.72 M(+7.3%) |
| Sept 2012 | - | $218.18 M(+23.6%) | $772.48 M(+5.3%) |
| June 2012 | - | $176.47 M(-5.5%) | $733.75 M(+0.8%) |
| Mar 2012 | $727.84 M(+7.6%) | $186.67 M(-2.3%) | $727.84 M(+2.3%) |
| Dec 2011 | - | $191.16 M(+6.5%) | $711.21 M(+2.1%) |
| Sept 2011 | - | $179.44 M(+5.2%) | $696.84 M(+1.8%) |
| June 2011 | - | $170.57 M(+0.3%) | $684.22 M(+1.1%) |
| Mar 2011 | $676.69 M(+4.8%) | $170.03 M(-3.8%) | $676.69 M(+0.1%) |
| Dec 2010 | - | $176.79 M(+6.0%) | $675.76 M(+1.7%) |
| Sept 2010 | - | $166.83 M(+2.3%) | $664.14 M(+1.5%) |
| June 2010 | - | $163.04 M(-3.6%) | $654.38 M(+1.4%) |
| Mar 2010 | $645.43 M(+8.0%) | $169.10 M(+2.4%) | $645.43 M(+2.7%) |
| Dec 2009 | - | $165.17 M(+5.2%) | $628.72 M(+1.6%) |
| Sept 2009 | - | $157.07 M(+1.9%) | $619.00 M(+1.8%) |
| June 2009 | - | $154.09 M(+1.1%) | $607.85 M(+1.7%) |
| Mar 2009 | $597.88 M(+15.8%) | $152.40 M(-2.0%) | $597.88 M(+2.3%) |
| Dec 2008 | - | $155.45 M(+6.5%) | $584.22 M(+3.7%) |
| Sept 2008 | - | $145.92 M(+1.3%) | $563.36 M(+4.6%) |
| June 2008 | - | $144.12 M(+3.9%) | $538.62 M(+4.3%) |
| Mar 2008 | $516.44 M | $138.74 M(+3.1%) | $516.44 M(+4.4%) |
| Dec 2007 | - | $134.59 M(+11.1%) | $494.62 M(+4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2007 | - | $121.18 M(-0.6%) | $473.56 M(+2.8%) |
| June 2007 | - | $121.94 M(+4.3%) | $460.87 M(+2.5%) |
| Mar 2007 | $449.61 M(+7.1%) | $116.92 M(+3.0%) | $449.61 M(+1.5%) |
| Dec 2006 | - | $113.53 M(+4.6%) | $443.08 M(+1.8%) |
| Sept 2006 | - | $108.49 M(-2.0%) | $435.23 M(+1.9%) |
| June 2006 | - | $110.67 M(+0.3%) | $427.23 M(+1.8%) |
| Mar 2006 | $419.73 M(+9.4%) | $110.39 M(+4.5%) | $419.73 M(+2.5%) |
| Dec 2005 | - | $105.68 M(+5.2%) | $409.31 M(+1.9%) |
| Sept 2005 | - | $100.49 M(-2.6%) | $401.73 M(+2.4%) |
| June 2005 | - | $103.17 M(+3.2%) | $392.17 M(+2.2%) |
| Mar 2005 | $383.60 M(+5.3%) | $99.97 M(+1.9%) | $383.60 M(+0.6%) |
| Dec 2004 | - | $98.10 M(+7.9%) | $381.34 M(+2.0%) |
| Sept 2004 | - | $90.92 M(-3.9%) | $373.98 M(+0.9%) |
| June 2004 | - | $94.60 M(-3.2%) | $370.55 M(+1.7%) |
| Mar 2004 | $364.23 M(+8.1%) | $97.72 M(+7.7%) | $364.23 M(+4.8%) |
| Dec 2003 | - | $90.74 M(+3.7%) | $347.39 M(+1.1%) |
| Sept 2003 | - | $87.49 M(-0.9%) | $343.77 M(+0.1%) |
| June 2003 | - | $88.28 M(+9.2%) | $343.30 M(+1.9%) |
| Mar 2003 | $336.96 M(+5.3%) | $80.88 M(-7.2%) | $336.96 M(+0.5%) |
| Dec 2002 | - | $87.11 M(+0.1%) | $335.13 M(+0.8%) |
| Sept 2002 | - | $87.03 M(+6.2%) | $332.42 M(+1.9%) |
| June 2002 | - | $81.94 M(+3.6%) | $326.10 M(+1.9%) |
| Mar 2002 | $319.97 M(+8.9%) | $79.05 M(-6.3%) | $319.97 M(+0.4%) |
| Dec 2001 | - | $84.41 M(+4.6%) | $318.61 M(+2.7%) |
| Sept 2001 | - | $80.70 M(+6.5%) | $310.10 M(+3.2%) |
| June 2001 | - | $75.80 M(-2.4%) | $300.34 M(+1.9%) |
| Mar 2001 | $293.86 M(+4.7%) | $77.70 M(+2.4%) | $294.81 M(+1.8%) |
| Dec 2000 | - | $75.90 M(+7.0%) | $289.62 M(+1.8%) |
| Sept 2000 | - | $70.94 M(+1.0%) | $284.52 M(+1.0%) |
| June 2000 | - | $70.27 M(-3.1%) | $281.78 M(+0.4%) |
| Mar 2000 | $280.61 M(-1.4%) | $72.51 M(+2.4%) | $280.61 M(-1.5%) |
| Dec 1999 | - | $70.80 M(+3.8%) | $284.91 M(+1.0%) |
| Sept 1999 | - | $68.20 M(-1.3%) | $282.11 M(+0.1%) |
| June 1999 | - | $69.10 M(-10.0%) | $281.71 M(-1.0%) |
| Mar 1999 | $284.51 M(-0.5%) | $76.81 M(+13.0%) | $284.61 M(+5.0%) |
| Dec 1998 | - | $68.00 M(+0.3%) | $271.10 M(-0.9%) |
| Sept 1998 | - | $67.80 M(-5.8%) | $273.60 M(-1.7%) |
| June 1998 | - | $72.00 M(+13.7%) | $278.30 M(-3.6%) |
| Mar 1998 | $285.80 M(-5.7%) | $63.30 M(-10.2%) | $288.60 M(-4.4%) |
| Dec 1997 | - | $70.50 M(-2.8%) | $301.80 M(-2.0%) |
| Sept 1997 | - | $72.50 M(-11.9%) | $307.90 M(-0.6%) |
| June 1997 | - | $82.30 M(+7.6%) | $309.80 M(+2.2%) |
| Mar 1997 | $303.00 M(+8.9%) | $76.50 M(-0.1%) | $303.00 M(+2.1%) |
| Dec 1996 | - | $76.60 M(+3.0%) | $296.90 M(+2.3%) |
| Sept 1996 | - | $74.40 M(-1.5%) | $290.20 M(+1.9%) |
| June 1996 | - | $75.50 M(+7.2%) | $284.90 M(+2.4%) |
| Mar 1996 | $278.20 M(+6.0%) | $70.40 M(+0.7%) | $278.20 M(+0.8%) |
| Dec 1995 | - | $69.90 M(+1.2%) | $276.00 M(+1.6%) |
| Sept 1995 | - | $69.10 M(+0.4%) | $271.70 M(+1.4%) |
| June 1995 | - | $68.80 M(+0.9%) | $267.90 M(+2.1%) |
| Mar 1995 | $262.40 M(+5.6%) | $68.20 M(+4.0%) | $262.40 M(+1.6%) |
| Dec 1994 | - | $65.60 M(+0.5%) | $258.30 M(+0.9%) |
| Sept 1994 | - | $65.30 M(+3.2%) | $255.90 M(+1.1%) |
| June 1994 | - | $63.30 M(-1.2%) | $253.20 M(+1.9%) |
| Mar 1994 | $248.40 M(+14.8%) | $64.10 M(+1.4%) | $248.40 M(+2.7%) |
| Dec 1993 | - | $63.20 M(+1.0%) | $241.80 M(+2.6%) |
| Sept 1993 | - | $62.60 M(+7.0%) | $235.70 M(+4.2%) |
| June 1993 | - | $58.50 M(+1.7%) | $226.20 M(+4.6%) |
| Mar 1993 | $216.30 M(+22.6%) | $57.50 M(+0.7%) | $216.30 M(+4.6%) |
| Dec 1992 | - | $57.10 M(+7.5%) | $206.80 M(+6.2%) |
| Sept 1992 | - | $53.10 M(+9.3%) | $194.70 M(+5.4%) |
| June 1992 | - | $48.60 M(+1.3%) | $184.80 M(+4.8%) |
| Mar 1992 | $176.40 M(+12.1%) | $48.00 M(+6.7%) | $176.30 M(+5.1%) |
| Dec 1991 | - | $45.00 M(+4.2%) | $167.70 M(+3.5%) |
| Sept 1991 | - | $43.20 M(+7.7%) | $162.00 M(+2.5%) |
| June 1991 | - | $40.10 M(+1.8%) | $158.10 M(+0.5%) |
| Mar 1991 | $157.30 M | $39.40 M(+0.3%) | $157.30 M(+33.4%) |
| Dec 1990 | - | $39.30 M(0.0%) | $117.90 M(+50.0%) |
| Sept 1990 | - | $39.30 M(0.0%) | $78.60 M(+100.0%) |
| June 1990 | - | $39.30 M | $39.30 M |
FAQ
- What is Haemonetics annual revenue?
- What is the all time high annual revenue for Haemonetics?
- What is Haemonetics annual revenue year-on-year change?
- What is Haemonetics quarterly revenue?
- What is the all time high quarterly revenue for Haemonetics?
- What is Haemonetics quarterly revenue year-on-year change?
- What is Haemonetics TTM revenue?
- What is the all time high TTM revenue for Haemonetics?
- What is Haemonetics TTM revenue year-on-year change?
What is Haemonetics annual revenue?
The current annual revenue of HAE is $1.31 B
What is the all time high annual revenue for Haemonetics?
Haemonetics all-time high annual revenue is $1.31 B
What is Haemonetics annual revenue year-on-year change?
Over the past year, HAE annual revenue has changed by +$140.40 M (+12.01%)
What is Haemonetics quarterly revenue?
The current quarterly revenue of HAE is $345.51 M
What is the all time high quarterly revenue for Haemonetics?
Haemonetics all-time high quarterly revenue is $345.51 M
What is Haemonetics quarterly revenue year-on-year change?
Over the past year, HAE quarterly revenue has changed by +$27.33 M (+8.59%)
What is Haemonetics TTM revenue?
The current TTM revenue of HAE is $1.36 B
What is the all time high TTM revenue for Haemonetics?
Haemonetics all-time high TTM revenue is $1.36 B
What is Haemonetics TTM revenue year-on-year change?
Over the past year, HAE TTM revenue has changed by +$121.99 M (+9.84%)